The import of heterocyclic compounds with an unfused imidazole ring to Germany is projected to exhibit steady growth from 2024 to 2028, increasing from 1.5534 million kilograms in 2024 to 1.5892 million kilograms in 2028. This highlights a year-on-year growth trend. Prior to these forecast years, in 2023, the actual import volume stood below these projection levels. The compound annual growth rate (CAGR) for the forecast period indicates consistent annual growth.
Looking ahead, factors influencing this market could include advancements in pharmaceutical applications, changes in trade policies, and sustainability trends. Monitoring these aspects is crucial for anticipating future shifts in import volumes.
